1. Background
2. Objectives
3. Patients and Methods
3.1. Participants
3.2. Tasks
3.3. Statistical Analysis
4. Results
4.1. VHI Results and Acoustic Parameters
a Abbreviations: T, total; P, physical; F, functional; E, emotional
b Group 1, patients with primary MTD (n = 12)
c Group 2, patients with secondary MTD (n = 6)
| Groups | Vowel | speech | ||||
|---|---|---|---|---|---|---|
| F0 | Jitt % a | Shim % a | Intensity | F0 a | Intensity | |
| Minimum Group 1 b | 136.93 | 0.16 | 1.89 | 43.71 | 154.29 | 40.93 |
| Maximum Group 1 | 442.86 | 10.36 | 22.32 | 72.25 | 443.53 | 62.68 |
| Mean Group 1 | 236.02 | 2.25 | 9.47 | 59.05 | 233.14 | 56.15 |
| SD Group 1 | 98.12 | 3.60 | 7.03 | 7.23 | 94.03 | 5.94 |
| Minimum Group 2 c | 118.11 | 0.46 | 3.20 | 48.84 | 179.78 | 45.98 |
| Maximum Group2 | 222.31 | 1.25 | 17.52 | 57.64 | 267.73 | 61.41 |
| Mean Group 2 | 191.46 | 0.79 | 10.33 | 53.18 | 208.69 | 54.48 |
| SD Group 2 | 38.36 | 0.30 | 5.22 | 3.57 | 34.94 | 5.20 |
aAbbreviations: Jitt %, jitter; Shim %, shimmer; F0, fundamental frequency
bGroup 1, patients with primary MTD (n = 12)
cGroup 2, patients with secondary MTD (n = 6)
4.2. Analysis of VHI and Acoustic Parameters
| Groups | Vowel | Speech | ||||
|---|---|---|---|---|---|---|
| F0 | Jitt % a | Shim % a | Intensity | F0 a | Intensity | |
| T a VHI Group 1 b | 0.636 c | 0.200 | -0.014 | -0.413 | 0.622 c | -0.070 |
| P a VHI Group 1 | 0.649 c | 0.260 | 0.070 | -0.544 | 0.558 | -0.182 |
| F a VHI Group 1 | 0.613 c | 0.171 | 0.132 | -0.531 | 0.635 c | -0.303 |
| E a VHI Group 1 | 0.592 c | -0.070 | -0.210 | -0.217 | 0.585 c | 0.025 |
| T VHI Group 2 d | 0.257 | 0.829 c | -0.143 | 0.486 | 0.429 | 0.543 |
| P VHI Group 2 | -0.543 | 0.314 | -0.486 | 0.086 | -0.143 | 0.029 |
| F VHI Group 2 | 0.377 | 0.493 | -0.319 | 0.725 | 0.464 | 0.812 c |
| E VHI Group 2 | 0.348 | 0.812 c | 0.058 | 0.145 | 0.406 | 0.239 |
aAbbreviations: T, total; P, physical; F, functional; E, emotional; Jitt %, jitter; Shim %, shimmer; F0, fundamental frequency.
bGroup 1, patients with primary MTD (n = 12)
cP < 0.05.
dGroup 2, patients with secondary MTD (n = 6)
